Re: Petros Grivas, Se Hoon Park, Eric Voog, et al. Avelumab First-line Maintenance Therapy for Advanced Urothelial Carcinoma: Comprehensive Clinical Subgroup Analyses from the JAVELIN Bladder 100 Phase 3 Trial. Eur Urol 2023;84:95-108

Eur Urol. 2023 Dec;84(6):e145. doi: 10.1016/j.eururo.2023.07.021. Epub 2023 Aug 31.
No abstract available

Publication types

  • Clinical Trial, Phase III
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Carcinoma, Transitional Cell* / drug therapy
  • Humans
  • Urinary Bladder
  • Urinary Bladder Neoplasms* / drug therapy

Substances

  • avelumab
  • Antibodies, Monoclonal, Humanized